Outpatient Management of Malignant Pleural Effusions with Small-Bore, Tunneled Pleural CathetersMusani A.I. · Haas A.R. · Seijo L. · Wilby M. · Sterman D.H.
Interventional Pulmonology Program, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, Pa., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Malignant pleural effusions (MPEs) can produce significant respiratory symptoms and diminished quality of life in patients with terminal malignancies. Control of MPEs to palliate respiratory symptoms can be performed via several different approaches. Ideally, a minimally invasive procedure to control MPEs and to provide relief of respiratory symptoms would be optimal. Objective: To ascertain if control of MPEs can be achieved by outpatient management via a small-bore pleural catheter (PC) without the need for sclerosing agents. Methods: Retrospective chart analysis of 24 patients after outpatient insertion of PCs for recurrent, symptomatic MPEs followed by frequent home drainage of pleural fluid to relieve respiratory symptoms. Results: Symptomatic relief of respiratory symptoms was achieved in 100% of patients, while pleurodesis was achieved in 58% of patients in a mean of 39 days. Five patients (6 PCs) expired with the catheters in place. In these patients, all catheters remained in position and functional until the patients ultimately died from nonpleural disease progression. No major complications occurred during insertion of the catheter. Late complications included localized cellulitis and bacterial superinfection in three patients and tumor growth at the catheter site in one patient. Conclusions: The PCs used in the present study provided an effective modality not only to alleviate respiratory symptoms associated with MPE, but also to achieve pleurodesis in 58% of our patients. These catheters may provide a significantly less invasive outpatient approach to the palliative management of MPEs.
© 2004 S. Karger AG, Basel
- Sahn SA: Malignant pleural effusions. Clin Chest Med 1985;6:113–125.
- Hausheer FH, Yarbro JW: Diagnosis and management of malignant pleural effusion. Semin Oncol 1985;12:54–75.
Lynch TJ Jr: Management of malignant pleural effusions. Chest 1993;103:385S–389S.
- Ruckdeschel JC: Management of malignant pleural effusions. Semin Oncol 1995;22:58–63.
- Anderson CB, Philpott GW, Ferguson TB: The treatment of malignant pleural effusions. Cancer 1974;33:916–922.
American Thoracic Society: Management of malignant pleural effusions, Am J Respir Crit Care Med 2000;162:1987–2001.
- Rodriguez-Panadero F, Antony VB: Pleurodesis: State of the art. Eur Respir J 1997;10:1648–1654.
- Viallat JR, Rey F, Astoul P, et al: Thoracoscopic talc poudrage pleurodesis for malignant effusions. Chest 1996;110:1387–1393.
- Sahn SA: Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907–1913.
- Colt HG: Thoracoscopic management of malignant pleural effusions. Clin Chest Med 1995;16:505–518.
- LoCicero J 3rd: Thoracoscopic management of malignant pleural effusion. Ann Thorac Surg 1993;56:641–643.
- Waller DA, Morritt GN, Forty J: Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 1995;107:1454–1456.
- Yim AP, Chung SS, Lee TW, et al: Thoracoscopic management of malignant pleural effusions. Chest 1996;109:1234–1238.
- Jensik R, Cagle JE, Milloy F, et al: Pleurectomy in the treatment of pleural effusion due to metastatic malignancy. J Thorac Cardiovasc Surg 1963;46:322–330.
Young D, Simon J, Pomerantz M: Current indications for and status of decortication for ‘trapped lung.’ Ann Thorac Surg 1972;14:631–634.
- Martin N, Bains MS, Beattie EJ: Indications for pleurectomy in malignant effusion. Cancer 1975;35:734–738.
- Leff RS, Eisenberg B, Baisden CE, et al: Drainage of recurrent pleural effusion via an implanted port and intrapleural catheter. Ann Intern Med 1986;104:208–209.
- Van Le L, Parker LA, DeMars LR, et al: Pleural effusions: Outpatient management with pigtail catheter chest tubes. Gynecol Oncol 1994;54:215–217.
Zeldin DC, Rodriguez RM: Management of refractory malignant pleural effusions with a chronic indwelling pleural catheter. Chest 1991;100:87S.
- Grodzin CJ, Balk RA: Indwelling small pleural catheter needle thoracentesis in the management of large pleural effusions. Chest 1997;111:981–988.
- Putnam JB, Light RW, Rodriguez RM, et al: A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992–1999.
- Clementsen P, Evald T, Grode G, et al: Treatment of malignant pleural effusion: Pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 1998;92:593–596.
- Marom EM, Patz EF Jr, Erasmus JJ, et al: Malignant pleural effusions: Treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999;210:277–281.
- Parker LA, Charnock GC, Delany DJ: Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer 1989;64:1218–1221.
- Patz EF Jr, McAdams HP, Erasmus JJ, et al: Sclerotherapy for malignant pleural effusions: A prospective randomized trial of bleomycin vs. doxycycline with small-bore catheter drainage. Chest 1998;113:1305–1311.
- Seaton KG, Patz EF Jr, Goodman PC: Palliative treatment of malignant pleural effusions: Value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR Am J Roentgenol 1995;164:589–591.
- Pien GW, Gant M, Washam C, Sterman DH: Use of an implantable pleural catheter for ‘trapped lung’ syndrome in patients with malignant pleural effusion. Chest 2001;119:1641–1646.
- Putnam JB Jr, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, DeFord LL: Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369–375.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.